Makes orthopedic implants and products for joint replacement, sports medicine and trauma, as well as surgical products and digital and robotic technologies for healthcare institutions and medical specialists.
10-K for FY2025, filed Feb 20, 2026Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We…View ↗
Our primary customers include orthopedic surgeons, neurosurgeons, and other specialists, healthcare institutions, stocking distributors…View ↗
ProductsView ↗
Our products include orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT products; bone…View ↗
Through our Technology & Data, Bone Cement and Surgical product category, we market a collective suite of our products and technologies as…View ↗
Sells directly to healthcare institutions such as hospitals and ambulatory surgery centers, and through stocking distributors and healthcare dealers. Orthopedic surgeons, neurosurgeons, other specialists and healthcare purchasing groups are also among its customers.
10-K for FY2025, filed Feb 20, 2026
Yes. It kept 9 cents of every revenue dollar as net income in FY2025 and turned 18 cents into free cash flow.
10-Q for Q3 FY2026, filed Nov 4, 2026
$191.6MView ↗
10-Q for Q3 FY2026, filed Nov 4, 2026
Open tableView ↗
8-K, filed Nov 4, 2026
2026 Reported Revenue Change 3.9% - 4.9% 4.4% - 4.9%View ↗
8-K, filed Apr 28, 2026
On April 22, 2026, Suketu Upadhyay informed Zimmer Biomet Holdings, Inc. (the “Company”) of his intention to resign from the position of…View ↗
Competes with Johnson & Johnson MedTech, Stryker, and Smith & Nephew
10-K for FY2025, filed Feb 20, 2026The orthopedics and broader musculoskeletal care industry is highly competitive. In the global markets for our knees, hips, and S.E.T.…View ↗
Loading...